title: Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD.
authors.affiliation: Department of Medical Oncology, Dr. BRA IRCH, All India Institute of Medical Sciences, New Delhi, 110 029, India.
authors.forename: Sainath
authors.initials: S
authors.lastname: Bhethanabhotla
authors.affiliation: Department of Medical Oncology, Dr. BRA IRCH, All India Institute of Medical Sciences, New Delhi, 110 029, India. sambakh@hotmail.com.
authors.forename: Sameer
authors.initials: S
authors.lastname: Bakhshi
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin